Department of Biotechnology, Thapar Institute of Engineering and Technology, Patiala, Punjab, India.
Pharmacol Res. 2020 Nov;161:105135. doi: 10.1016/j.phrs.2020.105135. Epub 2020 Aug 16.
The intestinal epithelial layer serves as a physical and functional barrier between the microbe-rich lumen and immunologically active submucosa; it prevents systemic translocation of microbial pyrogenic products (e.g. endotoxin) that elicits immune activation upon translocation to the systemic circulation. Loss of barrier function has been associated with chronic 'low-grade' systemic inflammation which underlies pathogenesis of numerous no-communicable chronic inflammatory disease. Thus, targeting gut barrier dysfunction is an effective strategy for the prevention and/or treatment of chronic disease. This review intends to emphasize on the beneficial effects of herbal formulations, phytochemicals and traditional phytomedicines in attenuating intestinal barrier dysfunction. It also aims to provide a comprehensive understanding of intestinal-level events leading to a 'leaky-gut' and systemic complications mediated by endotoxemia. Additionally, a variety of detectable markers and diagnostic criteria utilized to evaluate barrier improving capacities of experimental therapeutics has been discussed. Collectively, this review provides rationale for targeting gut barrier dysfunction by phytotherapies for treating chronic diseases that are associated with endotoxemia-induced systemic inflammation.
肠道上皮层作为富含微生物的腔与免疫活跃的黏膜下之间的物理和功能屏障;它可防止微生物热原性产物(如内毒素)的全身易位,这些产物易位到全身循环中会引发免疫激活。屏障功能的丧失与慢性“低度”全身炎症有关,后者是许多非传染性慢性炎症性疾病发病机制的基础。因此,靶向肠道屏障功能障碍是预防和/或治疗慢性疾病的有效策略。 本综述旨在强调草药配方、植物化学物质和传统植物药物在减轻肠道屏障功能障碍方面的有益作用。它还旨在提供对导致“肠漏”和内毒素血症介导的全身并发症的肠道水平事件的全面理解。此外,还讨论了用于评估实验治疗剂改善屏障能力的各种可检测标志物和诊断标准。总的来说,本综述为通过植物疗法靶向肠道屏障功能障碍以治疗与内毒素血症引起的全身炎症相关的慢性疾病提供了依据。